Evidence map›Paper›PMID 36895957›Full record

ArticleBrain communications2023

Investigating genotype-phenotype relationship of extreme neuropathic pain disorders in a UK national cohort.

Andreas C Themistocleous, Georgios Baskozos, Iulia Blesneac, Maddalena Comini, Karyn Megy, Sam Chong, Sri V V Deevi, Lionel Ginsberg, David Gosal, Robert D M Hadden and 15 more

Open access · goldAbstract read
In one paragraph

Article in Brain communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Genetic Analysis ofInternational journal of molecular sciences · 2024
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 11 institutions in 1 country.

Andreas C ThemistocleousNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-1089-1543
Georgios BaskozosNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Iulia BlesneacNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Maddalena CominiNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-9559-8839
Karyn MegyNIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge, UK.
Sam ChongNational Hospital for Neurology and Neurosurgery, University College London Hospitals, London, UK.
Sri V V DeeviNIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge, UK.
Lionel GinsbergDepartment of Neurology, Royal Free Hospital, London, UK.
David GosalSalford Royal NHS Foundation Trust, Salford, UK.
Robert D M HaddenKing's College Hospital NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-9702-0256
Rita HorvathWellcome Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
Mohamed Mahdi-RogersKing's College Hospital NHS Foundation Trust, London, UK.
Adnan ManzurGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Rutendo MapetaNIHR BioResource, Cambridge University Hospitals NHS Foundation, Cambridge, UK.
Andrew MarshallFaculty of Biology, Medicine and Health, School of Biological Sciences, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.ORCID https://orcid.org/0000-0001-8273-7089
Emma MatthewsDepartment of Neuromuscular Disease, UCL Queen Square Institute of Neurology and the National Hospital of Neurology and Neurosurgery, London, UK.ORCID https://orcid.org/0000-0002-3810-306X
Mark I McCarthyNIHR Oxford Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.
Mary M ReillyDepartment of Neuromuscular Disease, UCL Queen Square Institute of Neurology and the National Hospital of Neurology and Neurosurgery, London, UK.ORCID https://orcid.org/0000-0003-0686-905X
Tara RentonKing's College Hospital NHS Foundation Trust, London, UK.
Andrew S C RicePain Research, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.
Tom A ValeNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
Natalie van ZuydamNIHR Oxford Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.
Suellen M WalkerGreat Ormond Street Hospital for Children NHS Foundation Trust, London, UK.ORCID https://orcid.org/0000-0002-6086-9459
Christopher Geoffrey WoodsDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
David L H BennettNuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.ORCID https://orcid.org/0000-0002-7996-2696
University of Oxford · GBUniversity of Cambridge · GBKing's College Hospital NHS Foundation Trust · GBCentre for Human Genetics · GBGreat Ormond Street Hospital · GBNational Hospital for Neurology and Neurosurgery · GBChelsea and Westminster Hospital NHS Foundation Trust · GBRoyal London Hospital · GBSalford Royal NHS Foundation Trust · GBThe Royal Free Hospital · GBUniversity of Liverpool · GB

Funding

Medical Research Council MR/N025431/1Medical Research Council MR/S005021/1Medical Research Council MR/T020113/1Medical Research Council MR/V009346/1Medical Research Council MR/V037838/1Medical Research Council MR/W002388/1Medical Research Council MR/W002426/1Wellcome Trust
6 · The paper itself

Abstract

The aims of our study were to use whole genome sequencing in a cross-sectional cohort of patients to identify new variants in genes implicated in neuropathic pain, to determine the prevalence of known pathogenic variants and to understand the relationship between pathogenic variants and clinical presentation. Patients with extreme neuropathic pain phenotypes (both sensory loss and gain) were recruited from secondary care clinics in the UK and underwent whole genome sequencing as part of the National Institute for Health and Care Research Bioresource Rare Diseases project. A multidisciplinary team assessed the pathogenicity of rare variants in genes previously known to cause neuropathic pain disorders and exploratory analysis of research candidate genes was completed. Association testing for genes carrying rare variants was completed using the gene-wise approach of the combined burden and variance-component test SKAT-O. Patch clamp analysis was performed on transfected HEK293T cells for research candidate variants of genes encoding ion channels. The results include the following: (i) Medically actionable variants were found in 12% of study participants (205 recruited), including known pathogenic variants:

Indexed as

neuropathic painperipheral neuropathysodium channelswhole genome sequencing

Identifiers

PMID36895957
PMCPMC9991512
OpenAlexW4321471272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.